Cargando…

Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

In a phase I/IIa study of in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk‐3 gene (Ad‐REIC), we assessed the inhibitory effects of cancer recurrence after radical prostatectomy (RP), in patients with high risk localized prostate cancer (PCa). After completing the therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumon, Hiromi, Sasaki, Katsumi, Ariyoshi, Yuichi, Sadahira, Takuya, Araki, Motoo, Ebara, Shin, Yanai, Hiroyuki, Watanabe, Masami, Nasu, Yasutomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737302/ https://www.ncbi.nlm.nih.gov/pubmed/26621187 http://dx.doi.org/10.1111/cts.12362

Ejemplares similares

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy
por: Kumon, Hiromi, et al.
Publicado: (2015)

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
por: Kumon, H, et al.
Publicado: (2016)

Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review)
por: WATANABE, MASAMI, et al.
Publicado: (2014)

A second opinion pathology review improves the diagnostic concordance between prostate cancer biopsy and radical prostatectomy specimens
por: Maehara, Takanori, et al.
Publicado: (2021)

Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity
por: Ochiai, Kazuhiko, et al.
Publicado: (2015)

A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector
por: WATANABE, MASAMI, et al.
Publicado: (2014)

Impact of Sarcopenia on Erectile Function after Nerve-Sparing Robot-Assisted Radical Prostatectomy
por: Mitsui, Yosuke, et al.
Publicado: (2021)

Dkk3/REIC Deficiency Impairs Spermiation, Sperm Fibrous Sheath Integrity and the Sperm Motility of Mice
por: Xue, Ruizhi, et al.
Publicado: (2022)

ACT-15 AD-SGE-REIC GENE THERAPY FOR MALIGNANT GLIOMA
por: Kurozumi, Kazuhiko, et al.
Publicado: (2019)

A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy
por: Oka, Tetsuo, et al.
Publicado: (2016)

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2014)

Ureteroscopic Management of Chronic Unilateral Hematuria: A Single-Center Experience over 22 Years
por: Araki, Motoo, et al.
Publicado: (2012)

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
por: Hattori, Yasuhiko, et al.
Publicado: (2022)

Management of Groin Pain Using an Iliohypogastric Nerve Block in a Patient with Inguinal Hernia due to Persistent Müllerian Duct Syndrome
por: Sekito, Takanori, et al.
Publicado: (2021)

DNA methylation status of REIC/Dkk-3 gene in human malignancies
por: Hayashi, Tatsuro, et al.
Publicado: (2012)

Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
por: Lin, Wenfeng, et al.
Publicado: (2021)

Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells
por: Gohara, Yuma, et al.
Publicado: (2023)

Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors
por: Yoshinaga, Kasumi, et al.
Publicado: (2021)

Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity
por: Xu, Naijin, et al.
Publicado: (2020)

Intraluminal diamond‐like carbon coating with anti‐adhesion and anti‐biofilm effects for uropathogens: A novel technology applicable to urinary catheters
por: Watari, Shogo, et al.
Publicado: (2021)

Inflammatory myofibroblastic bladder tumor with divergent behavior in a patient with spinal cord injury
por: Tsuboi, Ichiro, et al.
Publicado: (2019)

Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma
por: Li, Xiezhao, et al.
Publicado: (2017)

The Genotypic and Phenotypic Characteristics Contributing to Flomoxef Sensitivity in Clinical Isolates of ESBL-Producing E. coli Strains from Urinary Tract Infections
por: Sakaeda, Kazuma, et al.
Publicado: (2023)

A Reddish Submucosal Tumor after Nephrectomy
por: Sadahira, Takuya, et al.
Publicado: (2017)

Feasibility of robot‑assisted radical cystectomy in a patient with an ectopic kidney: A case report
por: Edamura, Kohei, et al.
Publicado: (2022)

Significance of Neoadjuvant Hormonal Therapy in Radical Retropubic Prostatectomy: A Retrospective Single-Surgeon Study
por: Yamamichi, Fukashi, et al.
Publicado: (2013)

Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume
por: Tsuboi, Ichiro, et al.
Publicado: (2021)

Medical uses for phenol in the urinary tract: A possible forgotten treatment (Review)
por: Sadahira, Takuya, et al.
Publicado: (2021)

Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines
por: Kato, Yuiko, et al.
Publicado: (2017)

Photodynamic diagnostic ureteroscopy using the VISERA ELITE video system for diagnosis of upper-urinary tract urothelial carcinoma: a prospective cohort pilot study
por: Wada, Koichiro, et al.
Publicado: (2021)

Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository
por: Sekito, Takanori, et al.
Publicado: (2023)

A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment
por: FUJIO, KEI, et al.
Publicado: (2015)

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
por: Naiki, Taku, et al.
Publicado: (2012)

Prognostic differences among Grade Group 4 subgroups in robotic‐assisted radical prostatectomy
por: Sasaki, Takeshi, et al.
Publicado: (2022)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Feasible kidney donation with living marginal donors, including diabetes mellitus
por: Yoshinaga, Kasumi, et al.
Publicado: (2021)

Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell Carcinoma
por: Lin, Wenfeng, et al.
Publicado: (2022)

Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer
por: MA, CHAO, et al.
Publicado: (2014)

Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment
por: Lin, Wenfeng, et al.
Publicado: (2021)

Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy
por: Matsumoto, Kazuhiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrdoc2u1icih9lkaipg2u2h5va